mesalamine has been researched along with Anemia, Aplastic in 8 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient developed aplastic anemia four months after the start of mesalazine therapy." | 1.30 | Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor. ( Hosoya, T; Kaito, K; Kobayashi, M; Otsubo, H; Sekita, T; Shimada, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kidoguchi, K | 1 |
| Kubota, Y | 1 |
| Fujimoto, S | 1 |
| Sakata, Y | 1 |
| Kizuka-Sano, H | 1 |
| Yamaguchi, K | 1 |
| Ureshino, H | 1 |
| Katsuya, H | 1 |
| Ando, T | 1 |
| Esaki, M | 1 |
| Kimura, S | 1 |
| Wiesen, A | 1 |
| Wiesen, J | 1 |
| Limaye, S | 1 |
| Kaushik, N | 1 |
| Kishikawa, H | 1 |
| Nishida, J | 1 |
| Nakano, M | 1 |
| Hirano, E | 1 |
| Morishita, T | 1 |
| Ishii, H | 1 |
| Abboudi, ZH | 1 |
| Marsh, JC | 1 |
| Smith-Laing, G | 1 |
| Gordon-Smith, EC | 1 |
| Laidlaw, ST | 1 |
| Reilly, JT | 1 |
| Sharma, BC | 1 |
| Yachha, SK | 1 |
| Mishra, RN | 1 |
| Gupta, D | 1 |
| Otsubo, H | 1 |
| Kaito, K | 1 |
| Sekita, T | 1 |
| Shimada, T | 1 |
| Kobayashi, M | 1 |
| Hosoya, T | 1 |
| Anttila, PM | 1 |
| Välimäki, M | 1 |
| Pentikäinen, PJ | 1 |
1 review available for mesalamine and Anemia, Aplastic
| Article | Year |
|---|---|
Fatal aplastic anaemia after mesalazine.
Topics: Aged; Aminosalicylic Acids; Anemia, Aplastic; Colitis, Ulcerative; Fatal Outcome; Humans; Male; Mesa | 1994 |
7 other studies available for mesalamine and Anemia, Aplastic
| Article | Year |
|---|---|
Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.
Topics: Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Histocompatibility Antigens Class I; Humans; Intestina | 2021 |
Mesalazine-induced aplastic anemia.
Topics: Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Antilymphocyte Serum; Crohn Disease; Diag | 2009 |
Ulcerative colitis associated with aplastic anemia.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Blood Transfusion; Bone Marrow Examination; Colit | 2003 |
Antilymphocyte globulin for mesalazine-associated aplastic anaemia.
Topics: Aminosalicylic Acids; Anemia, Aplastic; Antilymphocyte Serum; Colitis, Ulcerative; Humans; Male; Mes | 1994 |
Hypoplastic anemia associated with ulcerative colitis in a child.
Topics: Aminosalicylic Acids; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Blood Trans | 1996 |
Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Antilymphocyte Serum; Cyclosporine | 1998 |
Pure-red-cell aplasia associated with sulphasalazine but not 5-aminosalicylic acid.
Topics: Adult; Aminosalicylic Acids; Anemia, Aplastic; Female; Humans; Mesalamine; Sulfasalazine | 1985 |